adagrasib,Pembrolizumab
mirati,merck
['pembro', 'lcsm,(-blcsm)', 'nsclc', 'sclc', 'adagrasib']
frontline adagrasib plus pembrolizumab elicits encouraging clinical activity in kras g12c+ advanced nsclc #lcsm #esmoimmuno22 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.